Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Cross-Linking for Infective Keratitis
NCT06967376Phase 1Completed
- Sponsor
- Research Institute of Ophthalmology
- Start
- May 2018
- Primary completion
- Nov 2021
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial in infectious keratitis (IK) (2 arms), sponsored by Research Institute of Ophthalmology. Primary endpoint: Clinical Response at Day 30. Started May 2018; status: completed.
02
Conditions
infectious keratitis (IK)
Beyond the preview
Go deeper on NCT06967376.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06967376.